Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Transfusion hemosiderosis

From Wikipedia, the free encyclopedia
Medical condition
Medical condition
Transfusion hemosiderosis
SpecialtyHematology
CausesFrequentblood transfusion
Diagnostic methodBloodtransferrin test,liver biopsy
Differential diagnosisOther causes ofhemosiderosis
TreatmentPhlebotomy,erythrocytapheresis
MedicationIronchelation therapy

Transfusional hemosiderosis is the accumulation ofiron in the body due to frequentblood transfusions. Iron accumulates in theliver andheart, but alsoendocrine organs. Frequent blood transfusions may be given to many patients, such as those withthalassemia,sickle cell disease,leukemia,aplastic anemia, ormyelodysplastic syndrome, among others. It is diagnosed with a bloodtransferrin test and aliver biopsy. It is treated withvenipuncture,erythrocytapheresis, and ironchelation therapy.

Signs and symptoms

[edit]

Transfusional hemosiderosis can causecardiac arrhythmia andcardiomyopathy.[1]

Causes

[edit]

Transfusional hemosiderosis is a potential side effect of frequentblood transfusions.[2] These may be given for a number of conditions, including:

Mechanism

[edit]

Hemoglobin, the oxygen-carrying molecule in ared blood cell, contains iron. The body has limited ways to store and remove iron. When red blood cells (RBCs) die, they are consumed bymacrophages. Transfused RBCs have shorter lifespans that native ones, so they die and are consumed more frequently by the macrophages, which causes the latter to die from excess iron which is then released into the blood.[2] Therefore, with frequent blood transfusions, iron builds up in the body over time.[2] This can enter theliver,heart,pancreas, andendocrine organs.[2] Free iron increases the production ofoxygen radicals (mostlyhydroxyl radicals) that cause damage to cells (particularly theirDNA).[2]

Diagnosis

[edit]

Transfusional hemosiderosis can be inferred with a bloodtransferrin test. Bloodferritin may be increased with a number of other conditions, so is less reliable for diagnosis.[4] Aliver biopsy may be used, which is the most accurate diagnostic technique.[4] The level of siderosis seen in a liver biopsy can be graded by severity.[2]

Treatment

[edit]

Transfusional hemosiderosis is treated with a number of therapies.Venipuncture (phlebotomy) removesblood.Erythrocytapheresis filtersred blood cells from the blood.Chelation therapy removes iron from the blood.[5] This involves delivering ironchelating agents such asdeferoxamine,deferiprone ordeferasirox.[5] If iron overload has caused damage to end-organs, this is generally irreversible and may requiretransplantation.[clarification needed]

Prognosis

[edit]

Transfusion hemosiderosis can cause permanent damage to tissues that may lead to death.[2] Tissue damage can remain even after chelation therapy.[2] Outcomes are usually worse in patients who require blood transfusions compared to those who can have alternative therapies.[2]Cardiomyopathy andcardiac arrhythmia are often a cause of death.[1]

Society

[edit]

Ted DeVita died of transfusional iron overload from too manyblood transfusions.[citation needed]

See also

[edit]

References

[edit]
  1. ^abHernando, Diego; Levin, Yakir S.; Sirlin, Claude B.; Reeder, Scott B. (2014)."Quantification of liver iron with MRI: State of the art and remaining challenges".Journal of Magnetic Resonance Imaging.40 (5):1003–1021.doi:10.1002/jmri.24584.ISSN 1522-2586.PMC 4308740.PMID 24585403.
  2. ^abcdefghiShander, A.; Cappellini, M. D.; Goodnough, L. T. (2009)."Iron overload and toxicity: the hidden risk of multiple blood transfusions".Vox Sanguinis.97 (3):185–197.doi:10.1111/j.1423-0410.2009.01207.x.ISSN 1423-0410.PMID 19663936.
  3. ^Sharma, Deva; Ogbenna, Ann Abiola; Kassim, Adetola; Andrews, Jennifer (April 2020)."Transfusion support in patients with sickle cell disease".Seminars in Hematology. Transfusion Support in Patients with Hematologic Disease: Transfusions in Special Clinical Circumstances.57 (2):39–50.doi:10.1053/j.seminhematol.2020.07.007.ISSN 0037-1963.PMID 32892842.S2CID 221523056.
  4. ^abBorgna-Pignatti, C; Castriota-Scanderbeg, A (September 1991)."Methods for evaluating iron stores and efficacy of chelation in transfusional hemosiderosis".Haematologica.76 (5):409–413.ISSN 1592-8721.PMID 1806447.
  5. ^abHider, Robert C.; Kong, Xiaole (2013). "Chapter 8. Iron: Effect of Overload and Deficiency". In Astrid Sigel, Helmut Sigel and Roland K. O. Sigel (ed.).Interrelations between Essential Metal Ions and Human Diseases. Metal Ions in Life Sciences. Vol. 13. Springer. pp. 229–294.doi:10.1007/978-94-007-7500-8_8.ISBN 978-94-007-7499-5.PMID 24470094.
Classification
Blood products
General concepts
Methods
Tests
Transfusion reactions
and adverse effects
Blood group systems
Retrieved from "https://en.wikipedia.org/w/index.php?title=Transfusion_hemosiderosis&oldid=1291894905"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp